Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Global change assessments in anti-Alzheimer clinical drug trials
David S. Knopman
Neurology
Research output
:
Contribution to journal
›
Article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Global change assessments in anti-Alzheimer clinical drug trials'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
United States Food and Drug Administration
100%
Alzheimer Disease
78%
Interviews
66%
Health Care Outcome Assessment
65%
Clinical Trials
65%
Physicians
63%
Pharmaceutical Preparations
41%